Syngene Q4 FY26 results: Rs. 1.25 final dividend; profit falls 36% YoY
SYNGENE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 8.9 pts more than Nifty Smallcap 250 and 8.9 pts more than its Healthcare Research Analytics & Technology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Syngene's board approved audited FY26 results with consolidated revenue of Rs. 37,387M (up 2.6% YoY from Rs. 36,424M) but net profit dropped to Rs. 3,167M from Rs. 4,962M due to exceptional items, including Labour Code gratuity impact (~Rs. 462M) and termination benefits. A final dividend of Rs. 1.25/share (face value Rs. 10) was recommended, record date June 26, 2026. S.R. Batliboi & Associates LLP appointed as statutory auditors for 5 years. 33rd AGM set for July 29, 2026.
Mixed for investors: topline grew modestly, but profit fell sharply on one-time Labour Code and gratuity charges. Final dividend is modest; margin recovery is the key watch item.